Nouveau Life Pharmaceuticals Stock Current Liabilities
| NOUV Stock | USD 0.0001 0.0001 50.00% |
Nouveau Life Pharmaceuticals fundamentals help investors to digest information that contributes to Nouveau Life's financial success or failures. It also enables traders to predict the movement of Nouveau Pink Sheet. The fundamental analysis module provides a way to measure Nouveau Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nouveau Life pink sheet.
Nouveau |
Nouveau Life Pharmaceuticals Company Current Liabilities Analysis
Nouveau Life's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Nouveau Life Current Liabilities | 146 K |
Most of Nouveau Life's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nouveau Life Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Nouveau Life Pharmaceuticals has a Current Liabilities of 146 K. This is 99.99% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Nouveau Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nouveau Life's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nouveau Life could also be used in its relative valuation, which is a method of valuing Nouveau Life by comparing valuation metrics of similar companies.Nouveau Life is currently under evaluation in current liabilities category among its peers.
Nouveau Fundamentals
| Return On Equity | -2.2 | |||
| Return On Asset | -0.2 | |||
| Current Valuation | 722.68 K | |||
| Price To Earning | (0.01) X | |||
| Price To Book | 22.72 X | |||
| EBITDA | (163.87 K) | |||
| Net Income | (357.25 K) | |||
| Cash And Equivalents | 1.1 K | |||
| Cash Flow From Operations | (22.91 K) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | -4.22 | |||
| Market Capitalization | 484.8 K | |||
| Total Asset | 1.33 M | |||
| Retained Earnings | (236 K) | |||
| Working Capital | (145 K) | |||
| Current Asset | 1 K | |||
| Current Liabilities | 146 K | |||
| Net Asset | 1.33 M |
About Nouveau Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nouveau Life Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nouveau Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nouveau Life Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nouveau Pink Sheet Analysis
When running Nouveau Life's price analysis, check to measure Nouveau Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nouveau Life is operating at the current time. Most of Nouveau Life's value examination focuses on studying past and present price action to predict the probability of Nouveau Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nouveau Life's price. Additionally, you may evaluate how the addition of Nouveau Life to your portfolios can decrease your overall portfolio volatility.